… Increased sympathetic and decreased parasympathetic activity contribute to heart failure (HF)
symptoms and disease progression. Baroreflex activation therapy (BAT) results in centrally …

… management of heart failure with reduced ejection fraction (HFrEF) have typically excluded
patients with advanced chronic kidney disease (… experience poor cardiovascular outcomes …

… heart failure. Fifty percent of these people have normal left ventricular (LV) systolic heart …
with hypertension, ischemic heart disease, atrial fibrillation, obesity, diabetes mellitus, renal …

… A fundamental characteristic in symptomatic chronic heart failure (HF), across all ejection
fractions (EFs), is the presence of an increase in cardiac filling pressures at rest or during …

… the management of heart failure (HF) was released. The aim of this study was to describe
the management of HF with reduced ejection fraction after the publication of ESC Guidelines. …

… treatment and end-of-life care. Clinical parameters, such as advanced age, higher NYHA
functional class, reduced left ventricular ejection fraction… More recently, heart failure biomarkers …

… is now termed heart failure with preserved ejection fraction (… to both heart failure with reduced
ejection fraction (HFrEF) … currently termed heart failure with mildly reduced ejection fraction (…

… with heart failure and reduced left ventricular ejection fraction (HFrEF). It is now recommended
to rapidly initiate all four pillars of life-saving HFrEF therapy [viz. angiotensin receptor–…

… care, in patients with any left ventricular ejection fraction (LVEF). … with chronic heart failure
with reduced ejection fraction (HFrEF) (… with heart failure with mildly reduced ejection fraction (…

… Heart failure with preserved ejection fraction (HFpEF) is a pathological complexity that
decreases cardiac output and elevates the ventricular … with no effective management guidelines. …